Tobacco industry issues management organizations: creating a global corporate network to undermine public health.

Globalization and Health
Patricia A McDanielRuth E Malone

Abstract

The global tobacco epidemic claims 5 million lives each year, facilitated by the ability of transnational tobacco companies to delay or thwart meaningful tobacco control worldwide. A series of cross-company tobacco industry "issues management organizations" has played an important role in coordinating and implementing common strategies to defeat tobacco control efforts at international, national, and regional levels. This study examines the development and enumerates the activities of these organizations and explores the implications of continuing industry cooperation for global public health. Using a snowball sampling strategy, we collected documentary data from tobacco industry documents archives and assembled them into a chronologically organized case study. The International Committee on Smoking Issues (ICOSI) was formed in 1977 by seven tobacco company chief executives to create common anti-tobacco control strategies and build a global network of regional and national manufacturing associations. The organization's name subsequently changed to INFOTAB. The multinational companies built the organization rapidly: by 1984, it had 69 members operating in 57 countries. INFOTAB material, including position papers and "action kits...Continue Reading

References

May 1, 1977·Journal of Advanced Nursing·D C Hall
Oct 19, 1978·The New England Journal of Medicine
Jan 1, 1991·Health Affairs·R J Blendon, K Donelan
Jun 1, 1991·American Journal of Public Health·D E Lilienfeld
Feb 1, 1986·American Journal of Public Health·K J Rothman
Oct 1, 1981·Journal of Medical Education·W H WehrmacherW C Randall
Nov 18, 1995·BMJ : British Medical Journal·S Kingman
Apr 1, 1993·Pediatric Pulmonology·A FalconerP Helms
May 20, 1998·American Journal of Public Health·D Yach, D Bettcher
May 30, 1998·JAMA : the Journal of the American Medical Association·D E Barnes, L A Bero
Jun 8, 2000·Tobacco Control·K Honjo, I Kawachi
Jun 8, 2000·Tobacco Control·D Yach, D Bettcher
Aug 5, 2000·BMJ : British Medical Journal·N Francey, S Chapman
Sep 12, 2000·Tobacco Control·B O'Sullivan, S Chapman
Sep 12, 2000·Tobacco Control·R E Malone, E D Balbach
Mar 15, 2002·Tobacco Control·C Mekemson, S A Glantz
Aug 16, 2002·The New England Journal of Medicine·James H Lutschg
Aug 29, 2002·Tobacco Control·M Assunta
Nov 5, 2002·Annual Review of Public Health·Lisa Bero
Nov 15, 2002·Tobacco Control·V B Yerger, R E Malone
Feb 25, 2003·Lancet·Derek Yach
Mar 28, 2003·American Journal of Public Health·Katherine Bryan-Jones, Lisa A Bero
May 30, 2003·American Journal of Public Health·Elizabeth A Smith, Ruth E Malone
Jun 7, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Monique E MuggliD Douglas Blanke
Dec 3, 2003·Tobacco Control·S M Carter
Apr 22, 2005·Public Health Reports·Lisa A Bero
Aug 4, 2005·European Journal of Public Health·Joaquin Barnoya, Stanton A Glantz
Dec 2, 2005·Tobacco Control·S M Carter
Dec 7, 2005·Environmental Health Perspectives·Patricia A McDanielRuth E Malone

❮ Previous
Next ❯

Citations

Mar 1, 2012·Cancer Causes & Control : CCC·Sungkyu LeeStanton A Glantz
Jun 17, 2009·Health Education Research·Robert C KlesgesRobert J Vanecek
Oct 28, 2008·Public Health Nursing·Elizabeth A Smith, Ruth E Malone
May 15, 2010·American Journal of Public Health·Ron BorlandJian Ying Zhang
Aug 18, 2012·American Journal of Public Health·Patricia A McDaniel, Ruth E Malone
Dec 4, 2009·CVD Prevention and Control·Raul MejiaEliseo J Pérez-Stable
Apr 19, 2011·Journal of Evaluation in Clinical Practice·Carmel M MartinBrendan O'Shea
Jun 4, 2014·The Milbank Quarterly·Rachel Ann BarryStanton A Glantz
Feb 16, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Catherine O EgbeStanton A Glantz
Jul 30, 2016·Tobacco Control·Heikki Hiilamo, Stanton Glantz
Feb 28, 2018·BMC Public Health·Seda Keklik, Derya Gultekin-Karakas
Oct 31, 2019·International Journal of Environmental Research and Public Health·Kathryn HyndmanSharon M Compton
Feb 29, 2020·JCO Global Oncology·Güldeniz Karadeniz ÇakmakVahit Ozmen
May 10, 2016·Mitochondrial DNA. Part A. DNA Mapping, Sequencing, and Analysis·Haiping LeeZhanjun Guo
Sep 19, 2021·Tobacco Control·Jawad A Al-Lawati, Stella A Bialous

❮ Previous
Next ❯

Software Mentioned

ITGA
InfoTab

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.